Trial of Chinese Prescription on Ulcerative Colitis

• Status: Completed
• Trial end date: 2011-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanghai University of Traditional Chinese Medicine

Criteria

Inclusion Criteria:

• Clinical diagnosis of ulcerative colitis

• Male of female patients between 18-65 years old

• Written informed consent

Exclusion Criteria:

• Combine with malignant pathology on epithelial dysplasia of mucosa

• Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.

• Pregnancy or breast feeding women, or unwilling to have contraception.